Purple Biotech Ltd (TA:KTOV) — Market Cap & Net Worth
Market Cap & Net Worth: Purple Biotech Ltd (KTOV)
Purple Biotech Ltd (TA:KTOV) has a market capitalization of $461.41K (ILA172.11 Million) as of June 17, 2026. Listed on the TA stock exchange, this Israel-based company holds position #30870 globally and #459 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Purple Biotech Ltd's stock price ILA1.00 by its total outstanding shares 172106000 (172.11 Million). Review debt load of Purple Biotech Ltd to assess the company's total debt and financial obligations.
Purple Biotech Ltd Market Cap History: 2015 to 2026
Purple Biotech Ltd's market capitalization history from 2015 to 2026. Data shows change from $562.92 Million to $461.41K (-54.02% CAGR).
Purple Biotech Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Purple Biotech Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
118.12x
Purple Biotech Ltd's market cap is 118.12 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $365.44 Million | $100.00K | -$12.27 Million | 3654.37x | N/A |
| 2018 | $121.81 Million | $1.00 Million | -$5.20 Million | 121.81x | N/A |
| 2019 | $118.12 Million | $1.00 Million | -$5.85 Million | 118.12x | N/A |
Competitor Companies of KTOV by Market Capitalization
Companies near Purple Biotech Ltd in the global market cap rankings as of June 17, 2026.
Key companies related to Purple Biotech Ltd by market ranking:
- Peptron Inc (KQ:087010): Ranked #5706 globally with a market cap of $2.41 Billion USD ( ₩3.56 Trillion KRW).
- Bioneer Corporation (KQ:064550): Ranked #18661 globally with a market cap of $117.85 Million USD ( ₩173.91 Billion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #18874 globally with a market cap of $111.42 Million USD ( ₩164.41 Billion KRW).
- Macrogen Inc (KQ:038290): Ranked #19496 globally with a market cap of $94.13 Million USD ( ₩138.90 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5706 | Peptron Inc | KQ:087010 | $2.41 Billion | ₩232500.00 |
| #18661 | Bioneer Corporation | KQ:064550 | $117.85 Million | ₩7870.00 |
| #18874 | MEDIPOST Co. Ltd | KQ:078160 | $111.42 Million | ₩10690.00 |
| #19496 | Macrogen Inc | KQ:038290 | $94.13 Million | ₩13860.00 |
Purple Biotech Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Purple Biotech Ltd's market cap moved from $562.92 Million to $ 461.41K, with a yearly change of -54.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA461.41K | -9.09% |
| 2025 | ILA507.55K | -86.25% |
| 2024 | ILA3.69 Million | -74.92% |
| 2023 | ILA14.72 Million | -38.06% |
| 2022 | ILA23.76 Million | -57.08% |
| 2021 | ILA55.37 Million | -4.23% |
| 2020 | ILA57.81 Million | -51.05% |
| 2019 | ILA118.12 Million | -3.03% |
| 2018 | ILA121.81 Million | -66.67% |
| 2017 | ILA365.44 Million | -32.99% |
| 2016 | ILA545.39 Million | -3.11% |
| 2015 | ILA562.92 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Purple Biotech Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $461.41K USD |
| MoneyControl | $461.41K USD |
| MarketWatch | $461.41K USD |
| marketcap.company | $461.41K USD |
| Reuters | $461.41K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Purple Biotech Ltd
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension i… Read more